Skip to content
中文产业新闻评分58Chinese source

艾力斯伏美替尼FURVENT试验未达到主要研究终点

国内卖出超百亿的抗癌药,海外“未达标”?

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.